Skip to main content

RIBER: 2025 FIRST-HALF BUSINESS – FULL-YEAR REVENUES EXPECTED TO EXCEED €40M

2025 FIRST-HALF BUSINESS

FULL-YEAR REVENUES EXPECTED TO EXCEED €40M

Bezons, July 23, 2025 – 8:00am – RIBER, the global leader in Molecular Beam Epitaxy (MBE) equipment for the semiconductor industry, reports its revenues for the first half of 2025.

Business developments

At June 30 (€m)20252024Change
Systems7.89.4-17%
Services and accessories3.04.3-31%
Total half-year revenues 10.713.7-22%

In a complex international environment, RIBER continues to demonstrate the resilience of its business model and the appeal of its technology offering.

The Company reiterates that its business activity is subject to seasonal trends, with revenue structurally lower in the first half of the year.

As of June 30, 2025, first-half revenues amounted to €10.7m, down 22% compared with the same period in 2024.

Systems revenues totaled €7.8m, down 17%, reflecting the delivery schedule agreed with customers for systems on order in 2025. This corresponds to the delivery of three machines, including two production systems, compared with three production systems in the same period last year.

Revenues for services and accessories came to €3.0m, down 31%, primarily due to a temporary decline in research-related orders, particularly in the United States, against a backdrop of tighter budgets in universities and research laboratories.

The geographical breakdown of half-year revenues was as follows: Europe (15%), Asia (70%) and North America (13%).

Order book developments

At June 30 (€m)20252024Change
Systems22.530.2-25%
Services and accessories5.25.8-11%
Total order book27.736.0-23%

Despite ongoing geopolitical tensions and regulatory constraints, RIBER maintained strong commercial momentum during the first half of 2025.
The Company secured five new system orders, including the first order for ROSIE, its new 300 mm silicon photonics platform, which recently entered its industrialization phase.

As of June 30, 2025, the systems order book stood at €22.5m, down 25% from the high base in the first half of 2024. It includes nine systems, of which six are production machines. This change is mainly due to the denial of two export licenses, representing €4m in unbooked orders, and longer license approval timelines, which delayed the booking of already-identified orders.

The services and accessories order book is down 11% to €5.2m.

Outlook

RIBER anticipates an improvement in order intake during the second half of the year, driven by major global investment programs in the semiconductor industry.

The Company also expects to benefit from the ramp-up of its ROSIE platform, a breakthrough technology in silicon-based integrated photonics. Following the signing of a strategic partnership with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) and the first unit sale, RIBER aims to leverage growing interest from both research institutions and industrial players for solutions compatible with silicon fabrication lines.

While short-term momentum in research-related services and accessories remains uncertain, the systems business is expected to remain broadly stable in 2025. These elements do not undermine the Company’s strong fundamentals.

Given the current order book for delivery this year and the upcoming business opportunities, RIBER expects to generate full-year revenue of over €40m in 2025.

Financial calendar

First-half 2025 results will be published on September 25, 2025, before the start of trading.

About RIBER

Founded in 1964, RIBER is the global market leader for MBE – molecular beam epitaxy – equipment. It designs and produces equipment for the semiconductor industry and provides scientific and technical support for its clients (hardware and software), maintaining their equipment and optimizing their performance and output levels. Accelerating the performance of electronics, RIBER’s equipment performs an essential role in the development of advanced semiconductors that are used in numerous applications, from information technologies to photonics (lasers, sensors, etc.), 5G telecommunications networks and research, including quantum computing. RIBER is a BPI France-approved innovative company and is listed on the Euronext Growth Paris market (ISIN: FR0000075954).
www.riber.com

Contacts

RIBER
Annie Geoffroy | tel: +33 (0)1 39 96 65 00 | invest@riber.com

ACTUS FINANCE & COMMUNICATION
Cyril Combe | tel: +33 (0)1 53 67 36 36 | ccombe@actus.fr

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.